Jitendriya Biswal

Jitendriya Biswal

Auto-generated profile, based on publicly available information

Jitendriya Biswal

IMS and SUM Hospital, Siksha 'O' Anusandhan (Deemed to be University), Department of Psychiatry, Bhubaneswar, Odisha, India

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2024 in Indian Journal of Psychological Medicine
Verified
Journal Article
Open access
JBJitendriya Biswal
Jitendriya Biswal
KAKritika Agarwal
Kritika Agarwal
MDMridul Deepanshu
Mridul Deepanshu
SSSurjeet Sahoo
Surjeet Sahoo

30 December 2022 in Health Leadership and Quality of Life
Verified
Journal Article
Open access
PDF file
HMH. Malathi
H. Malathi
JBJitendriya Biswal
Jitendriya Biswal
VSVarun Kumar Sharma
Varun Kumar Sharma
Introduction: The study explored innovative health leadership models aimed at enhancing the quality of life in post-acute care settings. It addressed the growing need for effective leadership strategies to improve patient outcomes and service delivery.Methods: The researcher employed a mixed-methods approach, combining quantitative surveys and qualitative interviews with healthcare professionals in various post-acute care facilities. The study analyzed data from 150 participants to evaluate the impact of different leadership models on care quality and staff satisfaction. Leadership models considered included transformational, transactional, and servant leadership.Results: The findings indicated that transformational leadership models significantly improved the quality of life for patients in post-acute care settings. Facilities that implemented this model reported higher patient satisfaction scores and better overall health outcomes compared to those using transactional and servant leadership models. Staff in transformational leadership settings also reported higher job satisfaction and lower burnout rates.Conclusions: The study concluded that transformational leadership is the most effective model for post-acute care settings, as it fosters a positive environment for both patients and staff. By prioritizing empathy, communication, and empowerment, transformational leaders can enhance patient care and improve job satisfaction among healthcare workers. The research recommended the adoption of transformational leadership training programs to cultivate these skills in current and future healthcare leaders, ultimately advancing the quality of life in post-acute care environments.

31 July 2025
Verified
Book Chapter
Open access
PDF file
JDJamuna Das
Jamuna Das
JBJitendriya Biswal
Jitendriya Biswal
Attention-deficit/hyperactivity disorder (ADHD) rarely manifests itself in isolation as a straightforward clinical syndrome but rather occurs in a mixture of clinically relevant neurodevelopmental, psychiatric, and somatic comorbidities. The heterogeneous manifestation of phenotypic forms highlights the interdisciplinarity of the methods involved, necessitating an integrated approach that draws from medical, psychological, educational, and sociocultural perspectives. It is this view of heterogeneity, or evidence of variability in clinical features of ADHD, that this chapter reflects upon. This chapter is primarily concerned with evidence-based interventions that facilitate the adoption of integrative diagnostic approaches and the implementation of multimodal treatment models. In the spirit of interdisciplinarity as well as individualized treatment models, this chapter aims to support a systems-based approach to ADHD that focuses on the maximization of function beyond symptom management and long-term adaptation. It supports integrated models of the multifactorial etiology of ADHD, as well as the psychosocial burden across the lifespan, while acknowledging the relevance of functional outcome assessment.

5 February 2026 in Neuropsychobiology
Verified
Journal Article
Open access
PDF file
LSLavanya Seth
Lavanya Seth
JBJitendriya Biswal
Jitendriya Biswal
SSSurjeet Sahoo
Surjeet Sahoo
RSRiya Shetty
Riya Shetty
JDJamuna Das
Jamuna Das
Introduction: Severe depressive episodes with suicidal ideation present major therapeutic challenges and often require interventions beyond standard antidepressant therapy. Electroconvulsive therapy (ECT) remains a cornerstone treatment for refractory depression, while ketamine, an N-methyl-D-aspartate receptor antagonist, has emerged as a rapid-acting antidepressant with potential benefits in reducing suicidal ideation. This study compares the efficacy, onset of action, and tolerability of intravenous ketamine and ECT as adjunctive treatments in severe major depressive disorder with active suicidal ideation. Methods: A randomised controlled trial was conducted at a tertiary care psychiatry department in India, enrolling 64 patients aged 18–60 years with severe depression (HAM-D ≥19, SSI ≥4). Participants were randomly assigned to receive either intravenous ketamine (n = 31) or ECT (n = 33), alongside ongoing oral antidepressants. Both groups underwent six treatment sessions over 2 weeks. Outcomes were assessed at baseline, post-treatment, and 4 weeks after completion. Primary endpoints included changes in depression severity (HAM-D) and suicidal ideation (SSI), while secondary outcomes included response and remission rates, as well as safety and tolerability profiles. Results: Both ECT and ketamine significantly reduced depressive symptoms and suicidal ideation (p < 0.001). HAM-D scores declined from 27 to 1 in the ECT group and from 26 to 2 in the ketamine group by the 4-week follow-up. SSI scores showed parallel improvement, from 12.1 to 1.2 with ECT and 12.6 to 2.0 with ketamine. Ketamine demonstrated a faster onset of clinical improvement, while ECT showed slightly greater durability of response. Side effects were mild in both groups, though ECT was associated with transient cognitive impairment, whereas ketamine produced minor dissociative and urinary symptoms. Conclusion: Ketamine offers a faster reduction in suicidal ideation than ECT, making it a promising acute intervention. Both are effective, safe adjunctive therapies, with treatment choice guided by patient profile and tolerability.

4 April 2025 in Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )
Verified
Journal Article
Open access
PDF file
JDJamuna Das
Jamuna Das
JBJitendriya Biswal
Jitendriya Biswal
RMRakesh Mohanty
Rakesh Mohanty
Background: Emotional regulation difficulties, depression, impulsivity, and anxiety are psychological factors that frequently co-occur with substance use in attention deficit hyperactivity disorder. These factors contribute to maladaptive coping strategies, increasing vulnerability to substance use patterns. Objective: To explore the psychological factors of the co-occurrence of ADHD with substance use, with a specific focus on emotional regulation, depression, impulsiveness, and anxiety. Methods: This cross-sectional study, conducted from September 2023 to September 2024 at a university in Eastern Odisha, explored psychological factors among undergraduate students aged 18–26 with ADHD and co-occurring substance use. Data collection utilizes validated tools, including ASRS-V1.1, ASSIST, HAM-D, HAM-A, DERS, and BIS. Results: The study analyzed 1,310 undergraduate students, showing 8.2% with ADHD, of which 52.3% reported substance use (SU). Impulsivity was significantly associated with SU, with higher impulsivity reported in SU individuals. Anxiety also showed a strong association with SU. However, emotional dysregulation and depression were not significantly linked to SU. These findings highlight key psychological factors influencing substance use in ADHD. Conclusions: This study underscores the significant role of impulsiveness and anxiety in the co-occurrence of substance use (SU) among individuals with ADHD, while emotional dysregulation and depression were not found to have a significant association. These findings highlight the need for targeted interventions addressing impulsiveness and anxiety to mitigate the risk of SU in this population.

30 December 2024 in Health Leadership and Quality of Life
Verified
Journal Article
Open access
PDF file
JKJamuna Kv
Jamuna Kv
UBUma Bhardwaj
Uma Bhardwaj
JGJagdish Gohil
Jagdish Gohil
JBJitendriya Biswal
Jitendriya Biswal
RNRaj Nimesh
Raj Nimesh
VPV. C. Patil
V. C. Patil
Objective: To anticipate changes in quality of life (QoL) evaluations for hemodialysis patients. over the course of the following month and to use ML to establish an early warning system. Materials and methods: A hospital with a dialysis unit hosted the trial, which lasted one month and included an approaching group. Approximately 78 patients have been enrolled up to this date. Preformed including demographic information MBBS-degree holding medical professionals administered the validated WHO-BREF. It has to be done again on the same patient a month later by the same investigator. R and Orange were used for machine learning, while SPSS version 24 was used to provide basic statistics.Results: In order to predict whether a patient's WHO-QOL-BREF score would increase or decrease by 5% over the course of a month, two models were developed using ML methods. A 5% or greater loss in QOL scores occurs over the course of the next month as a result of declines in the psychosomatic, substantial, and societal domain scores.Conclusion: The Dialysis Data Interpretation for Algorithmic-Prediction on QOL early warning system based on ML was developed to identify quickly declining QOL scores in the hemdialysis sample. The model suggested that improving the psychological and ecological domains in exacting could be able to arrest the fall in QOL ratings. If DIAL is used more widely, it should benefit patients by guaranteeing a greater QOL and reducing the long-term cost burden.